These findings indicate that pre-treatment CEA levels, pT staging, and pN staging are independent prognostic factors influencing survival in patients with rectal adenocarcinoma undergoing preoperative radiation therapy. The gene discussed is CEACAM5; the disease is rectum adenocarcinoma.